Kling Douglas F's Form 4 filing
NewAmsterdam Pharma Co N.V. (NAMS) · filed Jan 29, 2025
- Accession no.
- 0000950170-25-010575
- Filed
- Jan 29, 2025
- Trade date
- Jan 27-28, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 2 derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kling Douglas FCIK 0001699022 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 27, 2025 | Ordinary Shares | MOption exerciseAcquired | +104,174 | – | – | 148,174 | Direct | |
| Jan 27, 2025 | Ordinary Shares | SSaleDisposed | −80,359 | – | – | 67,815 | Direct | |
| Jan 27, 2025 | Ordinary Shares | SSaleDisposed | −23,815 | – | – | 44,000 | Direct | |
| Jan 28, 2025 | Ordinary Shares | MOption exerciseAcquired | +25,385 | – | – | 69,385 | Direct | |
| Jan 28, 2025 | Ordinary Shares | SSaleDisposed | −20,237 | – | – | 49,148 | Direct | |
| Jan 28, 2025 | Ordinary Shares | SSaleDisposed | −5,148 | – | – | 44,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 27, 2025 | Ordinary Shares | MOption exerciseDisposed | −104,174 | $0.00 | $0 | 321,971 | Direct | |
| Jan 28, 2025 | Ordinary Shares | MOption exerciseDisposed | −25,385 | $0.00 | $0 | 296,586 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.